SCHEMBL4464643

SCHEMBL4464643

Brc1cnc(C2CCCCN2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.45
CHRNA4 P43681 3/20 0.45
MEN1 O00255 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 2/20 0.45
CHRNA7 P36544 2/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2A6 P11509 1/20 0.45
CYP2C9 P11712 1/20 0.45
IDO1 P14902 2/20 0.35
TDO2 P48775 2/20 0.35
CHEK1 O14757 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
AURKA O14965 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474868 0.79 CHRNB2 (0.53) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL31512120 0.77 CHRNB2 (0.45) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL8100097 0.77 CHRNB2 (0.47) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL18884045 0.76 CHRNB2 (0.44) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL2636340 0.76 CHRNB2 (0.43) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL12644566 0.76 CHRNB2 (0.43) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL17155268 0.76 CHRNB2 (0.43) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL15747950 0.73 MEN1 (0.46) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL3921349 0.72 CHRNB2 (0.52) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL3921342 0.72 CHRNB2 (0.52) CHRNB2CHRNA4MEN1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306115-A1 Phenyl ethyne compounds MERCK SHARP & DOHME CORP. 2009-12-10 US disclosed
EP-1874724-A2 PHENYL ETHYNE COMPOUNDS Merck & Co., Inc. (US) 2008-01-09 EP disclosed
WO-2006115895-A2 PHENYL ETHYNE COMPOUNDS MERCK & CO., INC. (US) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306115-A1 Phenyl ethyne compounds DDT, CHRM3, CBR3 CHRNB2 78/4885CHRNA4 26/4885MEN1 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.